Arch Therapeutics, Inc.
Company Snapshot: Arch Therapeutics, Inc.
Arch Therapeutics, Inc. is a medical device company developing a novel approach to stop bleeding (hemostasis) and control leaking (sealant) during surgery and trauma care. Arch is developing products based on an innovative self-assembling peptide technology platform to make surgery and interventional care faster and safer for patients. Arch's flagship development stage product candidate, known as AC5 Surgical Hemostatic Device™, is being designed to achieve hemostasis in minimally invasive and open surgical procedures.
- Oct 25 2021 Arch Therapeutics to Present AC5 Advanced Wound System at 2021 Symposium on Advanced Wound Care (SAWC) Fall
- Oct 18 2021 Arch Therapeutics Launches Experts in Wound Care Program
- Oct 13 2021 Arch Therapeutics Provides Corporate Update
- Oct 6 2021 Arch Therapeutics to Present at the LD Micro Main Event